Company attributes
Industry
Location
B2X
0
Pitchbook URL
Number of Employees (Ranges)
11 – 500
Founded Date
2009
0Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Sangel Biomedical Venture Capital is a Shenzen based venture capital firm investing in biotechnology companies in China and abroad. It was established in 2010 to support high-tech enterprises in China and western countries. The company focuses on biomedicine, medical devices, healthcare, pharmaceutical, and livelihood security. In 2015, Sangel started its first international subsidiary, Sangel Venture Capital Corp in Chicago, United States. As of 2019, the company has made 16 investments in 15 portfolio companies with one successful exit.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.